Dáil Éireann Debate, Tuesday - 5 November 2024
1198. Deputy Jennifer Whitmore asked the Minister for Health the reasons the administration of interferon-alpha (details supplied) has been suspended; the alternative that is offered to patients previously on the drug; and if he will make a statement on the matter. [44901/24]
View answerIreland's medicines regulator, the Health Products Regulatory Authority (HPRA) has been notified of a shortage of Peginterferon-alfa-2a, brand name Pegasys, by pharmaand GmbH, the company responsible for placing Pegasys on the market. This represents a shortage impacting multiple markets, due to an unexpected increase in demand for Pegasys.
In respect of the latter part of your question, this has been referred to the HSE for their attention and direct answer.
